BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22342719)

  • 1. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli.
    Pandhal J; Desai P; Walpole C; Doroudi L; Malyshev D; Wright PC
    Biochem Biophys Res Commun; 2012 Mar; 419(3):472-6. PubMed ID: 22342719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse metabolic engineering to improve Escherichia coli as an N-glycosylation host.
    Pandhal J; Woodruff LB; Jaffe S; Desai P; Ow SY; Noirel J; Gill RT; Wright PC
    Biotechnol Bioeng; 2013 Sep; 110(9):2482-93. PubMed ID: 23568537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving N-glycosylation efficiency in Escherichia coli using shotgun proteomics, metabolic network analysis, and selective reaction monitoring.
    Pandhal J; Ow SY; Noirel J; Wright PC
    Biotechnol Bioeng; 2011 Apr; 108(4):902-12. PubMed ID: 21404263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Producing a glycosylating Escherichia coli cell factory: The placement of the bacterial oligosaccharyl transferase pglB onto the genome.
    Strutton B; Jaffé SRP; Pandhal J; Wright PC
    Biochem Biophys Res Commun; 2018 Jan; 495(1):686-692. PubMed ID: 29113801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.
    Pratama F; Linton D; Dixon N
    Microb Cell Fact; 2021 Oct; 20(1):198. PubMed ID: 34649588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glycosylation efficiency of recombinant proteins in Escherichia coli by auto-induction.
    Ding N; Yang C; Sun S; Han L; Ruan Y; Guo L; Hu X; Zhang J
    Biochem Biophys Res Commun; 2017 Mar; 485(1):138-143. PubMed ID: 28188786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.
    Ihssen J; Kowarik M; Wiesli L; Reiss R; Wacker M; Thöny-Meyer L
    BMC Biotechnol; 2012 Sep; 12():67. PubMed ID: 23006740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Metabolic Engineering for Enhanced Glycoprotein Production in Escherichia coli.
    Jaffé SR; Strutton B; Pandhal J; Wright PC
    Methods Mol Biol; 2015; 1321():17-35. PubMed ID: 26082212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome.
    Terra VS; Mauri M; Sannasiddappa TH; Smith AA; Stevens MP; Grant AJ; Wren BW; Cuccui J;
    Microb Cell Fact; 2022 Jan; 21(1):6. PubMed ID: 34986868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of glycoprotein vaccines in Escherichia coli.
    Ihssen J; Kowarik M; Dilettoso S; Tanner C; Wacker M; Thöny-Meyer L
    Microb Cell Fact; 2010 Aug; 9():61. PubMed ID: 20701771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and topology of bacterial oligosaccharyltransferase PglB.
    Li L; Woodward R; Ding Y; Liu XW; Yi W; Bhatt VS; Chen M; Zhang LW; Wang PG
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1069-74. PubMed ID: 20331969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.
    Kämpf MM; Braun M; Sirena D; Ihssen J; Thöny-Meyer L; Ren Q
    Microb Cell Fact; 2015 Jan; 14():12. PubMed ID: 25612741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications.
    Gupta SK; Shukla P
    Crit Rev Biotechnol; 2016 Dec; 36(6):1089-1098. PubMed ID: 26384140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli as a glycoprotein production host: recent developments and challenges.
    Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
    Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.
    Ihssen J; Haas J; Kowarik M; Wiesli L; Wacker M; Schwede T; Thöny-Meyer L
    Open Biol; 2015 Apr; 5(4):140227. PubMed ID: 25833378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple bacterial expression system for human ppGalNAc-T and used for the synthesis of O-GalNAc glycosylated interleukin 2.
    Liang T; Xu Z; Jia W; Zhang H; Yang F; Zou X; Zhang Y
    Biochem Biophys Res Commun; 2020 Aug; 529(1):57-63. PubMed ID: 32560819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
    Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
    Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level in vivo mucin-type glycosylation in Escherichia coli.
    Mueller P; Gauttam R; Raab N; Handrick R; Wahl C; Leptihn S; Zorn M; Kussmaul M; Scheffold M; Eikmanns B; Elling L; Gaisser S
    Microb Cell Fact; 2018 Oct; 17(1):168. PubMed ID: 30367634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Linked glycoengineering for human therapeutic proteins in bacteria.
    Pandhal J; Wright PC
    Biotechnol Lett; 2010 Sep; 32(9):1189-98. PubMed ID: 20449632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.